These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24386413)
1. Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation. Moroz A; Delella FK; Almeida R; Lacorte LM; Fávaro WJ; Deffune E; Felisbino SL PLoS One; 2013; 8(12):e84757. PubMed ID: 24386413 [TBL] [Abstract][Full Text] [Related]
2. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway. Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554 [TBL] [Abstract][Full Text] [Related]
4. Fibronectin induces MMP2 expression in human prostate cancer cells. Moroz A; Delella FK; Lacorte LM; Deffune E; Felisbino SL Biochem Biophys Res Commun; 2013 Jan; 430(4):1319-21. PubMed ID: 23261429 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Jeong JW; Jin CY; Park C; Han MH; Kim GY; Moon SK; Kim CG; Jeong YK; Kim WJ; Lee JD; Choi YH Int J Oncol; 2012 May; 40(5):1697-704. PubMed ID: 22246470 [TBL] [Abstract][Full Text] [Related]
6. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride. Byrns MC; Mindnich R; Duan L; Penning TM J Steroid Biochem Mol Biol; 2012 May; 130(1-2):7-15. PubMed ID: 22265960 [TBL] [Abstract][Full Text] [Related]
8. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma. Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530 [TBL] [Abstract][Full Text] [Related]
9. The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific. Chhipa RR; Halim D; Cheng J; Zhang HY; Mohler JL; Ip C; Wu Y Prostate; 2013 Oct; 73(14):1483-94. PubMed ID: 23813737 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition. Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer. Das K; Lorena PD; Ng LK; Lim D; Shen L; Siow WY; Teh M; Reichardt JK; Salto-Tellez M Endocr Relat Cancer; 2010 Sep; 17(3):757-70. PubMed ID: 20519274 [TBL] [Abstract][Full Text] [Related]
12. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560 [TBL] [Abstract][Full Text] [Related]
14. α-Solanine inhibits invasion of human prostate cancer cell by suppressing epithelial-mesenchymal transition and MMPs expression. Shen KH; Liao AC; Hung JH; Lee WJ; Hu KC; Lin PT; Liao RF; Chen PS Molecules; 2014 Aug; 19(8):11896-914. PubMed ID: 25116803 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors. Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697 [TBL] [Abstract][Full Text] [Related]
16. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals. Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427 [TBL] [Abstract][Full Text] [Related]
17. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system. Yang B; Zhang D; Qian J; Cheng Y Mol Cell Biochem; 2020 Nov; 474(1-2):199-208. PubMed ID: 32737771 [TBL] [Abstract][Full Text] [Related]
18. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453 [TBL] [Abstract][Full Text] [Related]
19. Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate. Delella FK; Justulin LA; Felisbino SL Int J Androl; 2010 Feb; 33(1):e114-22. PubMed ID: 19508332 [TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]